Literature DB >> 21636676

Poorer clock draw test scores are associated with greater functional impairment in peripheral artery disease: the Walking and Leg Circulation Study II.

Laura J Zimmermann1, Luigi Ferrucci, Jack M Guralnik, Michael H Criqui, Mary M McDermott.   

Abstract

We hypothesized that, in the absence of clinically recognized dementia, cognitive dysfunction measured by the clock draw test (CDT) is associated with greater functional impairment in men and women with peripheral artery disease (PAD). Participants were men and women aged 60 years and older with Mini-Mental Status Examination scores ≥ 24 with PAD (n = 335) and without PAD (n = 234). We evaluated the 6-minute walk test, 4-meter walking velocity at usual and fastest pace, the Short Physical Performance Battery (SPPB), and accelerometer-measured physical activity. CDTs were scored using the Shulman system as follows: Category 1 (worst): CDT score 0-2; Category 2: CDT score 3; Category 3 (best): CDT score 4-5. Results were adjusted for age, sex, race, education, ankle-brachial index (ABI), and comorbidities. In individuals with PAD, lower CDT scores were associated with slower 4-meter usual-paced walking velocity (Category 1: 0.78 meters/second; Category 2: 0.83 meters/second; Category 3: 0.86 meters/second; p-trend = 0.025) and lower physical activity (Category 1: 420 activity units; Category 2: 677 activity units; Category 3: 701 activity units; p-trend = 0.045). Poorer CDT scores were also associated with worse functional performance in individuals without PAD (usual and fast-paced walking velocity and SPPB, p-trend = 0.022, 0.043, and 0.031, respectively). In conclusion, cognitive impairment identified with CDT is independently associated with greater functional impairment in older, dementia-free individuals with and without PAD. Longitudinal studies are necessary to explore whether baseline CDT scores and changes in CDT scores over time can predict long-term decline in functional performance in individuals with and without PAD.

Entities:  

Mesh:

Year:  2011        PMID: 21636676      PMCID: PMC5076886          DOI: 10.1177/1358863X11407109

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  46 in total

1.  Correlates for a low ankle-brachial index in elderly Chinese.

Authors:  J Woo; H Lynn; S Y S Wong; A Hong; Y N Tang; W Y Lau; E Lau; E Orwoll; T C Y Kwok
Journal:  Atherosclerosis       Date:  2005-08-19       Impact factor: 5.162

2.  Executive function, working memory, and medication adherence among older adults.

Authors:  Kathleen Insel; Daniel Morrow; Barbara Brewer; Aurelio Figueredo
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2006-03       Impact factor: 4.077

3.  Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial.

Authors:  M Di Bari; M Pahor; L V Franse; R I Shorr; J Y Wan; L Ferrucci; G W Somes; W B Applegate
Journal:  Am J Epidemiol       Date:  2001-01-01       Impact factor: 4.897

4.  Cognitive and functional decline in adults aged 75 and older.

Authors:  Sandra A Black; Ronald D Rush
Journal:  J Am Geriatr Soc       Date:  2002-12       Impact factor: 5.562

5.  Lower extremity nerve function in patients with lower extremity ischemia.

Authors:  Mary M McDermott; Robert Sufit; Takashi Nishida; Jack M Guralnik; Luigi Ferrucci; Lu Tian; Kiang Liu; Jin Tan; William H Pearce; Joseph R Schneider; Leena Sharma; Michael H Criqui
Journal:  Arch Intern Med       Date:  2006-10-09

6.  Cognitive deficits in peripheral vascular disease. A comparison of mild stroke patients and normal control subjects.

Authors:  N A Phillips; C C Mate-Kole
Journal:  Stroke       Date:  1997-04       Impact factor: 7.914

7.  Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment.

Authors:  M M McDermott; P Greenland; K Liu; J M Guralnik; M H Criqui; N C Dolan; C Chan; L Celic; W H Pearce; J R Schneider; L Sharma; E Clark; D Gibson; G J Martin
Journal:  JAMA       Date:  2001-10-03       Impact factor: 56.272

8.  Cognitive decline and markers of inflammation and hemostasis: the Edinburgh Artery Study.

Authors:  Snorri B Rafnsson; Ian J Deary; Felicity B Smith; Martha C Whiteman; Ann Rumley; Gordon D O Lowe; F Gerald R Fowkes
Journal:  J Am Geriatr Soc       Date:  2007-05       Impact factor: 5.562

9.  Prognostic value of functional performance for mortality in patients with peripheral artery disease.

Authors:  Mary M McDermott; Lu Tian; Kiang Liu; Jack M Guralnik; Luigi Ferrucci; Jin Tan; William H Pearce; Joseph R Schneider; Michael H Criqui
Journal:  J Am Coll Cardiol       Date:  2008-04-15       Impact factor: 24.094

10.  Validity of the Clock-Drawing Test as a screening tool for cognitive impairment in the elderly.

Authors:  Yuji Nishiwaki; Elizabeth Breeze; Liam Smeeth; Christopher J Bulpitt; Ruth Peters; Astrid E Fletcher
Journal:  Am J Epidemiol       Date:  2004-10-15       Impact factor: 4.897

View more
  4 in total

1.  Community-based walking exercise for peripheral artery disease: An exploratory pilot study.

Authors:  Ryan J Mays; William R Hiatt; Ivan P Casserly; R Kevin Rogers; Deborah S Main; Wendy M Kohrt; P Michael Ho; Judith G Regensteiner
Journal:  Vasc Med       Date:  2015-03-09       Impact factor: 3.239

2.  Cognitive decrement in older adults with symptomatic peripheral artery disease.

Authors:  Andrew W Gardner; Polly S Montgomery; Ming Wang; Biyi Shen; Ana I Casanegra; Federico Silva-Palacios; Zoltan Ungvari; Andriy Yabluchanskiy; Anna Csiszar; Shari R Waldstein
Journal:  Geroscience       Date:  2021-09-09       Impact factor: 7.713

3.  Cognitive frailty: frontiers and challenges.

Authors:  A J Woods; R A Cohen; M Pahor
Journal:  J Nutr Health Aging       Date:  2013-09       Impact factor: 5.285

4.  Association between functional performance and executive cognitive functions in an elderly population including patients with low ankle-brachial index.

Authors:  Naomi Vidal Ferreira; Paulo Jannuzzi Cunha; Danielle Irigoyen da Costa; Fernando dos Santos; Fernando Oliveira Costa; Fernanda Consolim-Colombo; Maria Cláudia Irigoyen
Journal:  Clin Interv Aging       Date:  2015-05-06       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.